Gut–Liver–Pancreas Axis Crosstalk in Health and Disease: From the Role of Microbial Metabolites to Innovative Microbiota Manipulating Strategies

G Marroncini, L Naldi, S Martinelli, A Amedei - Biomedicines, 2024 - mdpi.com
The functions of the gut are closely related to those of many other organs in the human body.
Indeed, the gut microbiota (GM) metabolize several nutrients and compounds that, once …

Exploring the Potential of Fecal Microbiota Transplantation as a Therapy in Tuberculosis and Inflammatory Bowel Disease

A Boicean, D Bratu, SR Fleaca, G Vasile, L Shelly… - Pathogens, 2023 - mdpi.com
This review explores the potential benefits of fecal microbiota transplantation (FMT) as an
adjunct treatment in tuberculosis (TB), drawing parallels from its efficacy in inflammatory …

[HTML][HTML] A novel microRNA panel exhibited significant potential in evaluating the progression of laryngeal squamous cell carcinoma

L Zhang, Z Zhang, X Zheng, Y Lu, L Dai, W Li… - Non-coding RNA …, 2023 - Elsevier
Background Laryngeal squamous cell carcinoma (LSCC) is a common cancer of the head
and neck in humans. The 5-years survival rate of patients with LSCC have declined in the …

miR-155 and miR-21 as Diagnostic and Therapeutic Biomarkers for Ulcerative Colitis: There Is Still a Long Way to Go

D Onisor, O Brusnic, C Banescu, C Carstea, M Sasaran… - Biomedicines, 2024 - mdpi.com
(1) Elucidating the role of miRNAs (miRs) in ulcerative colitis may provide new insights into
disease pathogenesis, diagnosis, treatment, and monitoring We aimed to investigate …

Riddling substitution of “hsa” to “has” in the enigmatic microRNA nomenclature

R Vishwakarma, K Ramakrishnan… - OMICS: A Journal of …, 2024 - liebertpub.com
This concise review and analysis offers an initial unpacking of a previously under-
recognized issue within the microRNA research and communications field regarding the …

[HTML][HTML] Progress of Exosomal LncRNAs in Pancreatic Cancer

C Wei, C Zhang, Y Zhou, J Wang, Y Jin - International Journal of …, 2024 - mdpi.com
Pancreatic cancer is a prevalent malignant tumor with rising medication resistance and
mortality. Due to a dearth of specific and trustworthy biomarkers and therapeutic targets …

Inflammatory Bowel Disease Therapies and Acute Liver Injury

R Catanzaro, F Marotta, A Yazdani, M Sciuto - Toxics, 2024 - mdpi.com
Drug-induced liver disease (DILI) represents one of the main problems in the therapeutic
field. There are several non-modifiable risk factors, such as age and sex, and all drugs can …

Gut Microbiota Profile Changes in Patients with Inflammatory Bowel Disease and Non-Alcoholic Fatty Liver Disease: A Metagenomic Study

C De Caro, R Spagnuolo, A Quirino, E Mazza… - International Journal of …, 2024 - mdpi.com
Gut microbiota imbalances have a significant role in the pathogenesis of Inflammatory Bowel
Disease (IBD) and Non-Alcoholic Fatty Liver Disease (NAFLD). Herein, we compared gut …

Isorhapontigenin inhibition of basal muscle-invasive bladder cancer attributed to its downregulation of SNHG1 and DNMT3b

H Meng, R Yang, Q Lin, W Du, Z Chu, Y Cao, M Du… - BMC cancer, 2024 - Springer
Background Bladder cancer (BC) is among the most prevalent malignant urothelial tumors
globally, yet the prognosis for patients with muscle-invasive bladder cancer (MIBC) remains …

Exploring Advanced Therapies for Primary Biliary Cholangitis: Insights from the Gut Microbiota–Bile Acid–Immunity Network

Z Guo, K He, K Pang, D Yang, C Lyu, H Xu… - International Journal of …, 2024 - mdpi.com
Primary biliary cholangitis (PBC) is a cholestatic liver disease characterized by immune-
mediated injury to small bile ducts. Although PBC is an autoimmune disease, the …